Wells Fargo
MBOT icon

Wells Fargo’s Microbot Medical MBOT Stock Holding History

Wells Fargo’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21K Sell
8,734
-1
-0% -$2 ﹤0.01% 5756
2025
Q4 		$17.5K Sell
8,735
-1,635
-16% -$3.87K ﹤0.01% 5822
2025
Q3 		$31.6K Buy
10,370
+1,499
+17% +$4.67K ﹤0.01% 5683
2025
Q2 		$22.4K Sell
8,871
-7
-0.1% -$17 ﹤0.01% 5767
2025
Q1 		$13.4K Buy
8,878
+2
+0% +$4 ﹤0.01% 5817
2024
Q4 		$9.94K Sell
8,876
-12,542
-59% -$12.3K ﹤0.01% 5935
2024
Q3 		$19.1K Hold
21,418
– – ﹤0.01% 5652
2024
Q2 		$21.8K Buy
21,418
+8,628
+67% +$8.87K ﹤0.01% 5560
2024
Q1 		$15.7K Buy
12,790
+18
+0.1% +$23 ﹤0.01% 5638
2023
Q4 		$20.9K Buy
12,772
+6
+0% +$8 ﹤0.01% 5627
2023
Q3 		$17.7K Buy
12,766
+25
+0.2% +$54 ﹤0.01% 5644
2023
Q2 		$34.7K Buy
12,741
+12,554
+6,713% +$25.1K ﹤0.01% 5571
2023
Q1 		$390 Hold
187
– – ﹤0.01% 6613
2022
Q4 		$563 Sell
187
-61
-25% -$253 ﹤0.01% 6350
2022
Q3 		$1K Buy
248
+2
+0.8% +$10 ﹤0.01% 6391
2022
Q2 		$1K Buy
246
+4
+2% +$22 ﹤0.01% 6548
2022
Q1 		$1K Sell
242
-1
-0.4% -$6 ﹤0.01% 6824
2021
Q4 		$2K Sell
243
-999
-80% -$6.44K ﹤0.01% 6894
2021
Q3 		$8K Sell
1,242
-2
-0.2% -$15 ﹤0.01% 6274
2021
Q2 		$10K Hold
1,244
– – ﹤0.01% 6142
2021
Q1 		$11K Buy
1,244
+2
+0.2% +$17 ﹤0.01% 6319
2020
Q4 		$8K Hold
1,242
– – ﹤0.01% 6065
2020
Q3 		$10K Sell
1,242
-4
-0.3% -$28 ﹤0.01% 5897
2020
Q2 		$8K Buy
1,246
+1,000
+407% +$6.77K ﹤0.01% 5886
2020
Q1 		$1K Buy
246
+43
+21% +$377 ﹤0.01% 6068
2019
Q4 		$2K Buy
203
+1
+0.5% +$6 ﹤0.01% 6175
2019
Q3 		$1K Hold
202
– – ﹤0.01% 6277
2019
Q2 		$1K Sell
202
-1
-0.5% -$7 ﹤0.01% 6259
2019
Q1 		$2K Hold
203
– – ﹤0.01% 5863
2018
Q4 		$0 Buy
203
+1
+0.5% +$4 ﹤0.01% 6527
2018
Q3 		$2K Buy
202
+2
+1% +$17 ﹤0.01% 6234
2018
Q2 		$2K Hold
200
– – ﹤0.01% 6187
2018
Q1 		$2K Hold
200
– – ﹤0.01% 6201
2017
Q4 		$3K Hold
200
– – ﹤0.01% 6140
2017
Q3 		$4K Buy
+200
New +$3.53K ﹤0.01% 6071
2017
Q2 		– Hold
0
– – – 6357
2017
Q1 		– Hold
0
– – – 6416
2016
Q4 		– Hold
0
– – – 6364
2016
Q3 		– Sell
-1
Closed -$130 – 6274
2016
Q2 		$0 Hold
1
– – ﹤0.01% 6233
2016
Q1 		$0 Hold
1
– – ﹤0.01% 6330
2015
Q4 		$0 Hold
1
– – ﹤0.01% 6339
2015
Q3 		$0 Hold
1
– – ﹤0.01% 6337
2015
Q2 		$0 Hold
1
– – ﹤0.01% 6444
2015
Q1 		$2K Hold
1
– – ﹤0.01% 5978
2014
Q4 		$1K Hold
1
– – ﹤0.01% 6095
2014
Q3 		$2K Hold
1
– – ﹤0.01% 5993
2014
Q2 		$4K Hold
1
– – ﹤0.01% 5834
2014
Q1 		$2K Hold
1
– – ﹤0.01% 5688
2013
Q4 		$2K Hold
1
– – ﹤0.01% 5542
2013
Q3 		$2K Hold
1
– – ﹤0.01% 5451
2013
Q2 		$2K Buy
+1
New +$2.82K ﹤0.01% 5384

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Wells Fargo's MBOT Position: Q1 2026 in Review

Wells Fargo reduced its Microbot Medical (MBOT) stake by 0.01% in Q1 2026, selling an estimated $2 and leaving 8,734 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #5756.

Wells Fargo first reported a position in MBOT in Q2 2013 and has held it in 48 quarters since. The position peaked at $34.7K in Q2 2023. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Wells Fargo held 8,734 shares of Microbot Medical worth $21K as of Q1 2026.
  • Wells Fargo sold 1 Microbot Medical share in Q1 2026, an estimated $2.
  • Microbot Medical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5756 holding.
  • Wells Fargo first reported a position in Microbot Medical in Q2 2013 and has held it in 48 quarters since.
  • Wells Fargo's Microbot Medical position peaked at $34.7K in Q2 2023.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.